about
Analytical challenges in quantifying abiraterone with LC-MS/MS in human plasma.Drug-drug interaction potential in men treated with enzalutamide: Mind the gap.A clinically relevant decrease in abiraterone exposure associated with carbamazepine use in a patient with castration-resistant metastatic prostate cancer.The impact of patient characteristics on enzalutamide pharmacokinetics and how this relates to treatment toxicity and efficacy in metastatic prostate cancer patients
P50
description
researcher
@en
wetenschapper
@nl
name
Guillemette E Benoist
@en
Guillemette E Benoist
@nl
type
label
Guillemette E Benoist
@en
Guillemette E Benoist
@nl
prefLabel
Guillemette E Benoist
@en
Guillemette E Benoist
@nl
P31
P496
0000-0002-3432-3575